Aytu Biopharma (AYTU) Non-Current Deferred Tax Liability (2015 - 2023)

Aytu Biopharma (AYTU) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $100000.0 in Q2 2023.

• Non-Current Deferred Tax Liability for Q2 2023 came in at $100000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2023 was $100000.0 (changed 0.0% YoY), and the FY2023 annual result was $100000.0, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability held at $100000.0 in Q2 2023 per AYTU's latest filing, from $100000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $200000.0 in Q2 2021 and troughed at $100000.0 in Q3 2021.
• A 3-year average of $120000.0 and a median of $100000.0 in 2021 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability plunged 50.0% in 2022, then changed 0.0% in 2023.
• A 3-year view of Non-Current Deferred Tax Liability shows it stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023.
• Business Quant data shows AYTU's Non-Current Deferred Tax Liability at $100000.0 in Q2 2023, $100000.0 in Q2 2022, and $100000.0 in Q4 2021.